Risk factor
Very poor trading liquidity
Profitability factor
Solid dividends
About
Médica Sur, S.A.B. de C.V. functions as a leading healthcare provider within Mexico. The institution furnishes a comprehensive array of medical and surgical treatments, including intricate procedures such as bypass and gastric banding, cholecystectomy, inguinal hernia repair, liposculpture, breast augmentation, stereotactic radiosurgery, hip arthroplasty, knee and shoulder arthroscopy, spinal operations, lithiasis removal, and various prostate interventions, notably radical prostatectomy. Beyond these surgical offerings, Médica Sur also extends its services to include advanced radiotherapy, diagnostic imaging, comprehensive health check-ups, and medical insurance solutions. Established in 1966, this entity is headquartered in Mexico City and operates as a subsidiary of Neuco, SA de CV.
Company Valuation
From both historical and forecast perspectives, the stock is fairly priced compared to similar stocks. Specifically, the stock is fairly valued on P/E, neutral on EV/EBIT
Target Price
The average target price of MEDICAB.MX is 90 and suggests 53% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to in